A new medication for treatment-resistant depression may help a subset of people who carry a specific genetic marker.
The understanding of immune biology and the development of newer generations of immunotherapies have opened a new stage to ...
14h
Celltrion Signs Joint Research and Development Agreement with MustBio for Multi-Antibody New Drug
Celltrion announced on the 31st that it has signed a joint research and development agreement for a new immuno-oncology drug with MustBio, a domestic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback